massacre, page-30

Matty111

There is also a suggestion in the release, IMO - that the manufacturing improvement (expense) is essential to being competitive in Europe over the longer term - yes it means delayed gratification for the shareholders yet again, and while 125K isn't exactly showing us the money (Pete) - 12% YoY with a chance to grow market share is fairly compelling longer term narrative.

Bought more today - not seeing this as a problem, just a short term disappointment - glass half full.

--------------------

QUOTE: "This reduction in manufacturing cost is also expected to play an important role in maximising profits in non-US markets where the selling price of fondaparinux is significantly lower."